Guys , even if Amgen made their payment in Dec. , how would a "one-off payment "made by Amgen be classified as 'Receipts from customers" as that hardly meets the definition of "revenue from regular , on-going business activities .
I lean to the $17m not including a one-off payment from Amgen ....imo .
No doubt Oslo will argue that it also includes a payment from Abbvie !!
Q
- Forums
- ASX - By Stock
- UNS
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-48
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UNS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online